tiprankstipranks
Trending News
More News >
Dr. Martens Plc (GB:DOCS)
LSE:DOCS
UK Market

Dr. Martens Plc (DOCS) Share Forecast & Price Target

Compare
154 Followers
See the Price Targets and Ratings of:

DOCS Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
2 Buy
3 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Dr.
Martens Plc
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

DOCS Stock 12 Month Forecast

Average Price Target

97.40p
▲(44.62% Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Dr. Martens Plc in the last 3 months. The average price target is 97.40p with a high forecast of 114.00p and a low forecast of 76.00p. The average price target represents a 44.62% change from the last price of 67.35p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"49":"49p","82":"82p","115":"115p","65.5":"65.5p","98.5":"98.5p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":114,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">114.00p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97.4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">97.40p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":76,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">76.00p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[49,65.5,82,98.5,115],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,67.35,70.93846153846154,74.52692307692307,78.11538461538461,81.70384615384614,85.29230769230769,88.88076923076923,92.46923076923076,96.0576923076923,99.64615384615385,103.23461538461538,106.82307692307693,110.41153846153847,{"y":114,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,67.35,69.66153846153846,71.97307692307692,74.28461538461538,76.59615384615384,78.9076923076923,81.21923076923076,83.53076923076924,85.84230769230768,88.15384615384616,90.46538461538461,92.77692307692308,95.08846153846154,{"y":97.4,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,67.35,68.0153846153846,68.68076923076923,69.34615384615384,70.01153846153846,70.67692307692307,71.34230769230768,72.00769230769231,72.67307692307692,73.33846153846153,74.00384615384615,74.66923076923077,75.33461538461539,{"y":76,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":70.166,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":63.581,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":50.066,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":53.944,"date":1746057600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":57.822,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.541,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.474,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":97.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.9,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.6,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.35,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target114.00pAverage Price Target97.40pLowest Price Target76.00p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
85p
Hold
26.21%
Upside
Reiterated
01/28/26
Dr. Martens Plc (DOCS) Gets a Hold from Barclays
Berenberg Bank Analyst forecast on GB:DOCS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
114p
Buy
69.27%
Upside
Reiterated
01/27/26
Berenberg Bank Remains a Buy on Dr. Martens Plc (DOCS)
Goldman Sachs Analyst forecast on GB:DOCS
Goldman Sachs
Goldman Sachs
83p76p
Hold
12.84%
Upside
Reiterated
01/27/26
RBC Capital Analyst forecast on GB:DOCS
RBC Capital
RBC Capital
100p
Hold
48.48%
Upside
Reiterated
01/07/26
RBC Capital Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Peel Hunt
112p
Buy
66.30%
Upside
Reiterated
11/20/25
Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)
Deutsche Bank  Analyst forecast on GB:DOCS
Deutsche Bank
Deutsche Bank
80p
Hold
18.78%
Upside
Reiterated
07/11/25
Deutsche Bank Keeps Their Hold Rating on Dr. Martens Plc (DOCS)
Morgan Stanley Analyst forecast on GB:DOCS
Morgan Stanley
Morgan Stanley
70p
Hold
3.93%
Upside
Reiterated
06/05/25
Hold Rating on Dr. Martens Plc Amid Mixed Financial Performance and Strategic Shifts
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays
85p
Hold
26.21%
Upside
Reiterated
01/28/26
Dr. Martens Plc (DOCS) Gets a Hold from Barclays
Berenberg Bank Analyst forecast on GB:DOCS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
114p
Buy
69.27%
Upside
Reiterated
01/27/26
Berenberg Bank Remains a Buy on Dr. Martens Plc (DOCS)
Goldman Sachs Analyst forecast on GB:DOCS
Goldman Sachs
Goldman Sachs
83p76p
Hold
12.84%
Upside
Reiterated
01/27/26
RBC Capital Analyst forecast on GB:DOCS
RBC Capital
RBC Capital
100p
Hold
48.48%
Upside
Reiterated
01/07/26
RBC Capital Sticks to Its Hold Rating for Dr. Martens Plc (DOCS)
Peel Hunt
112p
Buy
66.30%
Upside
Reiterated
11/20/25
Peel Hunt Reaffirms Their Buy Rating on Dr. Martens Plc (DOCS)
Deutsche Bank  Analyst forecast on GB:DOCS
Deutsche Bank
Deutsche Bank
80p
Hold
18.78%
Upside
Reiterated
07/11/25
Deutsche Bank Keeps Their Hold Rating on Dr. Martens Plc (DOCS)
Morgan Stanley Analyst forecast on GB:DOCS
Morgan Stanley
Morgan Stanley
70p
Hold
3.93%
Upside
Reiterated
06/05/25
Hold Rating on Dr. Martens Plc Amid Mixed Financial Performance and Strategic Shifts
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Martens Plc

3 Months
xxx
Success Rate
2/2 ratings generated profit
100%
Average Return
+8.00%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +8.00% per trade.
1 Year
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.40%
reiterated a buy rating 2 months ago
Copying John Stevenson's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +1.40% per trade.
2 Years
xxx
Success Rate
1/2 ratings generated profit
50%
Average Return
+1.40%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +1.40% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

DOCS Analyst Recommendation Trends

Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
1
1
2
1
Buy
1
1
1
1
0
Hold
4
6
6
7
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
8
8
10
5
In the current month, DOCS has received 1 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. DOCS average Analyst price target in the past 3 months is 97.40.
Each month's total comprises the sum of three months' worth of ratings.

DOCS Financial Forecast

DOCS Earnings Forecast

Next quarter’s earnings estimate for DOCS is 0.05p with a range of 0.05p to 0.05p. The previous quarter’s EPS was >-0.01p. DOCS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.42% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.
Next quarter’s earnings estimate for DOCS is 0.05p with a range of 0.05p to 0.05p. The previous quarter’s EPS was >-0.01p. DOCS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.42% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.

DOCS Sales Forecast

Next quarter’s sales forecast for DOCS is 447.14M with a range of 442.00M to 452.28M. The previous quarter’s sales results were 322.00M. DOCS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.54% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.
Next quarter’s sales forecast for DOCS is 447.14M with a range of 442.00M to 452.28M. The previous quarter’s sales results were 322.00M. DOCS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.54% of the time in the same period. In the last calendar year DOCS has Performed in-line its overall industry.

DOCS Stock Forecast FAQ

What is GB:DOCS’s average 12-month price target, according to analysts?
Based on analyst ratings, Dr. Martens Plc’s 12-month average price target is 97.40.
    What is GB:DOCS’s upside potential, based on the analysts’ average price target?
    Dr. Martens Plc has 44.62% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Dr. Martens Plc a Buy, Sell or Hold?
          Dr. Martens Plc has a consensus rating of Moderate Buy, which is based on 2 buy ratings, 3 hold ratings and 0 sell ratings.
            What is Dr. Martens Plc’s share price target?
            The average share price target for Dr. Martens Plc is 97.40. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is 114.00p ,and the lowest forecast is 76.00p. The average share price target represents 44.62% Increase from the current price of 67.35p.
              What do analysts say about Dr. Martens Plc?
              Dr. Martens Plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of Dr. Martens Plc?
                To buy shares of GB:DOCS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.